All stock lists
Unlock the score
Biomerica Inc (BMRA)
NASDAQ: BMRA · Real-Time Price · USD
Healthcare · Medical Devices
1.76+0.08 (+5.02%)
Insider Score
/ 100
BMRA Insider Score
BIOMERICA INC has a live Insider Score.
Scored on 5 qualifying trades from 5 insiders in the last 90 days.
Financial Health Score
Weak
From BMRA’s reported statements · Q3 2026 (trailing 12 months)
Profitability0 / 20
Loses money on what it sells.
- Revenue
- $4.3M
- Net income
- -$5.0M
- Net margin
- -115.5%
Leverage14 / 20
A manageable debt load.
- Total debt
- $2.3M
- Cash
- $2.7M
- Debt / equity
- 0.64
Liquidity19 / 20
Comfortably covers what is due within a year.
- Current assets
- $5.4M
- Current liabilities
- $2.8M
- Current ratio
- 1.91
Cash generation0 / 20
Consumes cash and must keep raising it.
- Operating cash flow
- -$4.0M
- Free cash flow
- -$4.0M
- FCF margin
- -92.0%
Dilution & runway0 / 20
Burning cash with under a year of runway — expect a raise.
- Shares outstanding
- 3.3M
- Share growth (1y)
- 24.9%
- Cash runway
- 8 months
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
BMRA Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Aug 31, 2026 | May 31, 2026 | Feb 28, 2026 | Nov 30, 2025 | Aug 31, 2025 | Feb 28, 2025 |
| Revenue | 1.26 M | 875.00 K | 987.00 K | 1.21 M | 1.38 M | — |
| Revenue Growth (YoY) | -8.33 % | — | — | — | — | — |
| Cost of Revenue | 1.16 M | 946.00 K | 1.03 M | 1.16 M | 956.00 K | — |
| Gross Profit | 103.00 K | -71.00 K | -44.00 K | 51.00 K | 424.00 K | — |
| SG&A Expense | 1.12 M | 1.26 M | 1.08 M | 1.23 M | 1.33 M | — |
| R&D Expense | 206.00 K | 205.00 K | 178.00 K | 193.00 K | 212.00 K | — |
| Operating Expenses | 1.33 M | 1.46 M | 1.25 M | 1.42 M | 1.54 M | — |
| Operating Income | -1.23 M | -1.53 M | -1.30 M | -1.37 M | -1.12 M | — |
| Pretax Income | -1.23 M | -1.14 M | -1.30 M | -1.31 M | 5.00 K | — |
| Tax Provision | 6.00 K | 6.00 K | 8.00 K | 5.00 K | 3.00 K | — |
| Net Income | -1.23 M | -1.15 M | -1.31 M | -1.32 M | 2.00 K | — |
| EPS (Basic) | -0.37 | — | -0.44 | -0.45 | 0.00 | -0.48 |
| EPS (Diluted) | -0.37 | — | -0.44 | -0.45 | 0.00 | -0.48 |
| Shares Outstanding | 3.30 M | — | 3.01 M | 2.91 M | 2.64 M | 2.40 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.